Scientists, entrepreneurs, and biotech executives will discuss their work developing next-generation neuroscience therapies and technologies in areas such as spinal-cord injuries, precision mental health, addiction, dementia, and Alzheimer’s.
Registration & Networking: 3 – 4 p.m. Program: 4 – 5:30 p.m. Reception: 5:30 – 6:30 p.m.
Recent relevant Xconomy coverage:
Can AI Tools, $76M Lead BlackThorn to Targeted Psych Drugs? Alector IPO Banks $176M to Test Alzheimer’s Drugs in Clinical Trials With $2M Seed, Perlstein Lab Tests Unorthodox Rare-Disease Plan
Agenda details coming soon…
Business, life sciences, and technology news — covering
Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2019, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from
Andrew Koyfman with design support from Rob Hunter.